Table 2.

BSI Outcomes

BSI Information	Value
Hurler patients with a BSI, n/N (%)	12/25 (48)
Total BSIs	16
BSIs by stem cell source, n/N (%)
Cord blood	10/16 (63)
Bone marrow	6/16 (37)
BSIs by conditioning regimen, n/N (%)
MAC	11/16 (69)
RIC	5/16 (31)
BSIs by HLA matching, n/N (%)
Matched related	1/16 (6)
Matched unrelated	11/16 (69)
Mismatched unrelated	4/16 (25)
Infection type, n/N (%)
Monomicrobial infections	3/16 (81)
Polymicrobial infections	3/16 (19)
Organisms identified, n (%)	20
Staphylococcus aureus	4 (20)
Klebsiella pneumoniae	3 (15)
Escherichia coli	2 (10)
Staphylococcus epidermidis	2 (10)
Actinomyces odontolyticus	1 (5)
Enterococcus faecalis	1 (5)
Moraxella osloensis	1 (5)
Pseudomonas aeruginosa	1 (5)
Coagulase-negative Staphylococcus	1 (5)
Staphylococcus haemolyticus	1 (5)
Streptococcus agalactiae	1 (5)
Streptococcus mitis/oralis	1 (5)
Streptococcus viridans	1 (5)
Time to infection, d, median (IQR)	33 (6.5–128.5)

MAC indicates myeloablative conditioning; RIC, reduced-intensity conditioning.